A detailed history of Exane Derivatives transactions in Nuveen Credit Strategies Income Fund stock. As of the latest transaction made, Exane Derivatives holds 3,507 shares of JQC stock, worth $20,270. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,507
Previous 3,507 -0.0%
Holding current value
$20,270
Previous $21,000 14.29%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022

SELL
$5.76 - $6.59 $27,072 - $30,973
-4,700 Reduced 57.27%
3,507 $21,000
Q4 2021

Jan 28, 2022

SELL
$6.22 - $6.6 $45,362 - $48,133
-7,293 Reduced 47.05%
8,207 $53,000
Q3 2020

Oct 06, 2020

BUY
$5.76 - $6.2 $89,280 - $96,100
15,500 New
15,500 $91,000

Others Institutions Holding JQC

About Nuveen Credit Strategies Income Fund


  • Ticker JQC
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Nuveen Credit Strategies Income Fund is a closed-ended balanced mutual fund launched by Nuveen Investments, Inc. The fund is managed by Symphony Asset Management, LLC. It invests in the fixed income and public equity markets of the United States. The fund invests in senior secured and second lien loans, preferred securities, convertible securiti...
More about JQC
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.